WHO ICTRP trial
Two maintenance doses of 5 and 10 mg caffeine citrate on the patent ductus…
IRCT20240929063204N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20240929063204N1 |
|---|---|
| Public title | Two maintenance doses of 5 and 10 mg caffeine citrate on the patent ductus arteriosus (PDA) in very low birth weight infants |
| Scientific title | The comparison of two maintenance doses of 5 and 10 mg caffeine citrate on the frequency of patent ductus arteriosus (PDA) in very low birth weight infants |
| Primary sponsor | Babol University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 1-2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Patent Ductus Arteriosus. Diseases of the blood and blood-forming organs;D70-D77 |
| Interventions | Intervention 1: Intervention group: Caffeine citrate with a dose of 10mg/kg per day. Intervention 2: Control group: Intervention group: Caffeine citrate with a dose of 5mg/kg per day. |
| Registration date | Oct 21, 2024 |
| Target size | 90 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: